"I am glad that taking part in a trial might help others on their own cancer journey.”
A trial looking at comparing the delivery of treatment for cancer in the community and hospital (OUTREACH)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This trial looked at comparing the delivery of cancer drug treatment at the hospital, at the family doctor (GP) surgery and at home.
Most people have cancer drugs at the hospital where they see their cancer doctors. Because of new and improved ways of giving cancer drugs, it may be possible to give cancer drugs in the community. This may also be better for patients.
When this trial started, Addenbrooke’s Hospital in Cambridge and West Suffolk Hospital in Bury St Edmunds were looking at setting up a service to give cancer drugs at GP surgeries or in people’s own homes.
The aims of this trial were to find out
- How patients feel about having treatment at home or the GP surgery
- The cost of giving treatment in different settings
- How safe it is
Summary of results
The research team found that having treatment in the community was acceptable, safe and cost effective.
The trial recruited 97 people, who were put into 1 of 3 groups at random.
- 32 people had treatment at the hospital
- 33 people had treatment at home
- 32 people had treatment at their GP surgery
For various reasons, the research team was only able to analyse the results of 57 people who took part. They found that people were happy to have their treatment in the community as well as at the hospital.
The research team found that more people preferred to have treatment in one of the community settings (their home or a GP surgery) rather than at the hospital. Of the two community settings, people treated in their own home seemed to be happier than those treated at the GP surgery.
They also found there was no difference between the overall cost or the safety of having treatment in difference places.
The research team concluded that, although this trial was small, it did support the development of cancer services in the community.
We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists (
How to join a clinical trial
Dr Pippa Corrie
Cambridge University Hospitals NHS Foundation Trust
NIHR Clinical Research Network: Cancer
NIHR Research for Patient Benefit (RfPB) Programme